Results 1 to 10 of about 1,678,519 (353)

Clinical Evaluation of Risankizumab in the Treatment of Adults with Moderately to Severely Active Crohn’s Disease: Patient Selection and Reported Outcomes

open access: yesDrug Design, Development and Therapy, 2023
Sara Horst,1 Raymond K Cross2 1Vanderbilt University Medical Center, Nashville, TN, USA; 2University of Maryland School of Medicine, Baltimore, MD, USACorrespondence: Sara Horst, Vanderbilt University Medical Center, Inflammatory Bowel Disease Clinic ...
Horst S, Cross RK
doaj  

Antibiotics for induction and maintenance of remission in Crohn's disease.

open access: yesCochrane Database of Systematic Reviews, 2017
BACKGROUND Several antibiotics have been evaluated in Crohn's disease (CD), however randomised controlled trials (RCTs) have produced conflicting results.
C. Townsend   +6 more
semanticscholar   +1 more source

Induction of remission in autoimmune polyglandular syndrome type three (APS III): An old drug with new perspectives

open access: yesClinical Case Reports, 2018
Key Clinical Message The autoimmune polyglandular syndrome is a sequential chain of autoimmune events. Whenever diagnosed, the clinician's target should be induction of remission and if possible hindering its progression especially if associated with ...
Magdy Mohamed Allam   +1 more
doaj   +1 more source

REAL-WORLD EXPERIENCE WITH JANUS KINASE INHIBITORS IN EXTRAINTESTINAL MANIFESTATIONS AND INFLAMMATORY BOWEL DISEASE IN COLOMBIA: A COMPARATIVE STUDY (JAKEIM-IBD STUDY) [PDF]

open access: yesArquivos de Gastroenterologia
Background: Extraintestinal manifestations (EIMs) significantly impact patients with inflammatory bowel disease (IBD). Janus kinase inhibitors (JAKi) are emerging as a potential treatment.
Viviana PARRA-IZQUIERDO   +8 more
doaj   +1 more source

RESULTS OF CHEMOTHERAPY BY UKCCSG PROTOCOL IN CHILDREN WITH ACUTE LYMPHOBLASTIC LEUKEMIA : CLINICAL CHARACTERISTICS AND OUTCOME [PDF]

open access: yes
Objectives: Acute lymphoblastic leukemia (ALL) represents a clonal expansion and arrest of normal lymphoid hematopoiesis. ALL remains the most common malignancy in children.
جاسب, کاوه   +4 more
core  

Seven-year follow-up of infliximab therapy in rheumatoid arthritis patients with severe long-standing refractory disease : attrition rate and evolution of disease activity [PDF]

open access: yes, 2010
Introduction: This study is based on the results from a Belgian expanded access program in which patients with active refractory and erosive rheumatoid arthritis (RA) were treated with intravenous infusions of infliximab in combination with methotrexate.
Vander Cruyssen, Bert   +3 more
core   +1 more source

Neuroactive steroids in depression and anxiety disorders: Clinical studies [PDF]

open access: yes, 2006
Certain neuroactive steroids modulate ligand-gated ion channels via non-genomic mechanisms. Especially 3 alpha-reduced pregnane steroids are potent positive allosteric modulators of the gamma-aminobutyric acid type A (GABA(A)) receptor.
Akwa Y   +79 more
core   +1 more source

Dermatomyositis as paraneoplastic syndrome of peritoneal and ovarian relapse after long-term complete remission in patient with metastatic bilateral breast cancer [Dermatomiozitis kao paraneoplastički sindrom peritonealnog i ovarijalnog relapsa nakon dugog perioda potpune remisije u bolesnice s metastatskim bilateralnim rakom dojke] [PDF]

open access: yes, 2012
Dermatomyositis is a rare disease characterised by inflammatory muscle affection and characteristic cutaneous changes. When occuring in a patient with cancer, dermatomyositis may indicate recurrence or progression and poor outcome.
Bolanča, Ante   +5 more
core  

Early prediction of treatment outcome in acute myeloid leukemia by measurement of WT1 transcript levels in peripheral blood samples collected after chemotherapy

open access: yesHaematologica, 2008
The Wilms’ tumor gene WT1 is a reliable marker for minimal residual disease assessment in acute leukemia patients. The study was designed to demonstrate the potential use of WT1 to establish quality of remission in acute leukemia patients for early ...
Daniela Cilloni   +15 more
doaj   +1 more source

Efficacy of remission-induction regimens for ANCA-associated vasculitis.

open access: yesNew England Journal of Medicine, 2013
BACKGROUND The 18-month efficacy of a single course of rituximab as compared with conventional immunosuppression with cyclophosphamide followed by azathioprine in patients with severe (organ-threatening) antineutrophil cytoplasmic antibody (ANCA ...
U. Specks   +30 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy